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ABSTRACT
Selection has been invaluable for genetic manipula-
tion, although counter-selection has historically ex-
hibited limited robustness and convenience. TolC, an
outer membrane pore involved in transmembrane
transport in E. coli, has been implemented as a
selectable/counter-selectable marker, but counter-
selection escape frequency using colicin E1
precludes using tolC for inefficient genetic manipula-
tions and/or with large libraries. Here, we leveraged
unbiased deep sequencing of 96 independent
lineages exhibiting counter-selection escape to
identify loss-of-function mutations, which offered
mechanistic insight and guided strain engineering
to reduce counter-selection escape frequency by
40-fold. We fundamentally improved the tolC
counter-selection by supplementing a second
agent, vancomycin, which reduces counter-selection
escape by 425-fold, compared colicin E1 alone.
Combining these improvements in a mismatch
repair proficient strain reduced counter-selection
escape frequency by 1.3E6-fold in total, making
tolC counter-selection as effective as most
selectable markers, and adding a valuable tool to
the genome editing toolbox. These improvements
permitted us to perform stable and continuous
rounds of selection/counter-selection using tolC,
enabling replacement of 10 alleles without requiring
genotypic screening for the first time. Finally, we
combined these advances to create an optimized
E. coli strain for genome engineering that is
10-fold more efficient at achieving allelic diversity
than previous best practices.
INTRODUCTION
Selectable markers have long been critical tools in molecu-
lar genetics, enabling the genetic manipulation of
model organisms. Classical selectable markers are often
antibiotic resistance genes, such as aminoglycoside
phosphotransferase (kanamycin resistance), whose gene
products are required for growth in media containing
kanamycin. Selectable markers are used for plasmid main-
tenance, engineered conjugation and genome manipula-
tions (1). In contrast, counter-selectable markers such as
sacB (2) or barnase (3) are useful tools for different appli-
cations, such as plasmid curing (4,5), scar-less gene
deletion (2) or engineering double-crossovers (6).
However, counter-selectable markers often require strin-
gent growth conditions to achieve robust counter-selection
performance, and there are few means to ensure proper
function of counter-selectable markers in vivo, which
limit their application. Because selectable and counter-
selectable markers have desirable and nonredundant
uses, markers with both selectable and counter-selectable
selection schemes (‘dual selectable markers’) are uniquely
powerful and versatile. Dual selectable markers are par-
ticularly advantageous for generating gene replacements,
scar-less genome editing and selection-coupled biosensors
(7). Several dual selectable markers have been reported
[rpsL (8,9), galK (10), thyA (11), hsvTK (12), tetA (13)
and tolC (14)], but as with counter-selectable markers,
dual-selectable markers suffer from high counter-selection
escape and/or reliance on minimal media for robust
counter-selection (10).
Without a suitable dual selectable marker, notable
genome engineering projects have relied on cumbersome
workarounds. For example, the Keio collection of
Escherichia coli single-gene deletion clones was generated
through kanR cassette replacement of each coding region,
followed by FLP-based deletion of the kanR cassette (15),
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which scars the genome and risks off-target recombination
elsewhere on the genome. In another example, separate
selectable and counter-selectable markers were used
together as a facsimile of a dual selectable maker to
engineer protein substrate speciﬁcity and reactivity (3)
without a means to ensure function of the counter-
selectable marker. Finally, to minimize the E. coli
genome, Posfai et al. (16) implemented a cloning-intensive
method relying on I-sceI-induced double-strand break
repair for scar-less serial deletion of genome segments.
In each of these cases, a robust dual selectable marker
would have been more convenient, suffered from less
counter-selection escape, enabled scarless editing, and
thus provided a more scalable approach for these or
other more ambitious projects.
We were motivated to develop robust dual selectable
markers to address these deﬁciencies, and to augment the
power of Multiplex Automatable Genome Engineering
(MAGE) (17). MAGE leverages  Red recombineering
in E. coli (18–20) to introduce mismatches, insertions
and deletions onto the host genome, permitting explor-
ation of evolutionary potential by rapidly generating com-
binatorial allelic diversity in a mixed population. Recent
advances in MAGE have increased the average number of
edits per MAGE cycle by reducing oligonucleotide deg-
radation (1,21,22), manipulating the replisome (23) and
co-selecting for recombinant genomes using Co-Selection
MAGE (CoS-MAGE) (24,25). CoS-MAGE selects for
recombinants by pairing a recombination to ﬁx a broken
selectable marker with nearby recombinations to
introduce other edits of interest. Applying the associated
selection leverages the signiﬁcant linkage between nearby
recombination events to enrich for highly modiﬁed clones
after one cycle (24,25). However, MAGE is amenable to
stable cycling, while CoS-MAGE using a selectable
marker can only be performed once before the selectable
marker must be inactivated anew. Without a robust dual
selectable marker, CoS-MAGE is not amenable to repeti-
tive cycling and requires time-intensive screening tech-
niques that greatly limit its power and versatility.
We chose the dual selectable marker, tolC, as a test case
for optimization because it is associated with convenient
selections that can be performed in either liquid or solid,
rich media (14). The tolC gene encodes a 1.5-kb monomer
of a homotrimer pore (Supplementary Figure S1A). TolC
is anchored in the outer membrane, spans the periplasm
(PP) and provides a route for efﬂux of a wide variety
of compounds. As summarized in Supplementary Figure
S1B, TolC provides resistance to sodium dodecyl sulfate
(SDS), and confers sensitivity to bactericidal colicin E1
(colE1) (26). While SDS selection is highly robust, tolC+
strains can readily escape from colE1-based counter-selec-
tion, for example, oligonucleotide-based deletion of tolC
exhibits counter-selection escape rates of less than 0.01 up
to 0.75, when tested at a variety of loci in the E. coli
genome (14). These escape rates preclude the use of tolC
for genomic manipulations that occur at frequencies lower
than this range. To improve the counter-selection
performance of tolC, we applied a generalizable,
high-throughput workﬂow, including whole genome
re-sequencing of 96 independent clones harboring a
counter-selection escape phenotype and duplicating the
genes whose loss-of-function alleles cause this phenotype.
Additionally, we demonstrated that pairing vancomycin
with colE1 reduces counter-selection escape frequency by
requiring that escape mutations break both counter-
selection mechanisms. Whereas continuous CoS-MAGE
cycling using tolC was not possible owing to counter-se-
lection escape, our improved strain and selection condi-
tions allowed us to use tolC to rapidly converge on highly
modiﬁed populations, offering one example of how a
robust dual-selectable marker exhibiting minimal
counter-selection escape will beneﬁt many applications in
molecular biology and genome engineering.
MATERIALS AND METHODS
Strains and culture methods
The strains used in this work were derived from EcNR2
(Escherichia coli MG1655 mutS::cat (ybhB-
bioAB)::[cI857 N(cro-ea59)::tetR-bla]) (17). We generated
EcM1.0 (‘EcM’, E. coliMAGE-optimized) by inactivating
the xonA, exoX and xseA nucleases (22) and by modulating
primase activity [dnaG_Q576A, (23)]. We generated
EcM2.0 by duplicating tolQRA at position 1 255 700 in
EcM1.0. All strains were grown in liquid culture using
the Lennox formulation of lysogeny broth (LBL) (27)
with appropriate selective agents: carbenicillin (50mg/ml),
chloramphenicol (20 mg/ml), SDS (0.005%w/v) and vanco-
mycin (64mg/ml). During tolC counter-selections in liquid
media, colicin E1 (colE1) was used at a 1:100 dilution from
an in-house puriﬁcation (28) that measured 14.4 mgprotein/ml
(1,29). Growth kinetics of representative tolC+ and tolC
strains under these culture conditions are presented in the
Supplementary Figures S1C–H).
Colicin E1 agar plates
Clonal JC411 (28) isolates were picked, then passaged into
1 L LBL production cultures. At OD600=0.1, we induced
colicin E1 expression using 0.5 mg/ml of mitomycin-C, and
then incubated cultures overnight at 37C. Cultures were
cooled on ice, then centrifuged at 9000 relative centrifugal
force (rcf) for 10min at 4C. The pellets were resuspended
in LBL, washed by centrifugation at 4000 rcf for 5min at
4C, and resuspended in 50mM K2HPO4, pH 7.55. The
pellets were sonicated on ice using a probe sonicator
(Misonix Sonicator 3000), outputting 21–24W, using
30 s on/30 s off cycles for 10 total minutes. Sonicates
were clariﬁed by centrifugation at 16 100 rcf for 5min.
These sonicates were added to molten LBL agar+Carb
(12.5mL of sonicate per 1L of media). The colicin
plates were protected from light, stored at 4C and ex-
hibited a shelf life of 4 weeks.
Oligonucleotides, polymerase chain reaction and
isothermal assembly
A complete list of oligonucleotides used in this study is
listed in Supplementary Table S6.
All polymerase chain reaction (PCR) products to be
used in recombination or Sanger sequencing were
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ampliﬁed with Kapa Biosystems High-Fidelity polymer-
ase, according to the manufacturer’s instructions.
Multiplex allele-speciﬁc PCR (mascPCR) was used for
multiplexed genotyping using the KAPA2G Fast
Multiplex PCR Kit, according to previous methods
(22,23). Sanger sequencing reactions were carried out
through a third party (Genewiz, Eton Biosciences). To
assemble multiple DNA fragments into a single contigu-
ous sequence, we used isothermal assembly at 50C for
60min (30).
Lambda red recombinations, MAGE and CoS-MAGE
Lambda red recombineering, the basis for MAGE and
CoS-MAGE, was carried out as described previously
(17,22,23). In singleplex recombinations, [oligo]=1 mM.
In <5-plex recombinations, [oligo]each=1 mM. In multi-
plexed recombinations (CoS-MAGE) with 10+ oligos,
[selectable oligo]=0.2 mM, whereas [nonselectable
oligo]total=5 mM. Oligos were designed to hybridize to
the lagging strand of the replication fork, as optimized
previously (31). When double-stranded PCR products
were recombined, 100 ng of double-stranded PCR
product was used.
CoS-MAGE modeling
The input data for CoS-MAGE modeling were the geno-
types of the 10 targeted loci from 92 clones of a population
of EcNR2.nuc5-.dnaG_Q576A cells that had been sub-
jected to one cycle of CoS-MAGE (Figure 1AB, far
right bar). The 92 genotypes from that data deﬁned the
probabilities of allele replacement (AR) patterns in a
representative CoS-MAGE cycle. A complete description
of the model is included in the Supplement.
tolC-based selections
For recombinations inserting tolC or those reactivating
tolC, cultures were recovered from electroporation for at
least 1 h before applying the tolC selection using SDS. For
recombinations deleting or inactivating tolC, cultures were
recovered from electroporation for 5 hours, then passaged
1:100 into fresh LBL for 2 hours before inoculating the
counter-selection, using 1:100 colE1 (28). Growth kinetics
of representative tolC+ and tolC- strains under these
culture conditions are presented in the (Supplementary
Figure S1F and G). Kinetic monitoring of colE1 and
SDS selections was performed on a shaking spectropho-
tometer (Spectramax M3, M5 or Biotek H4) at 34C.
To quantify performance of liquid selections, we
included a number of control selections that allowed us
to devise a metric, called Normalized Selection Advantage
(NSA, deﬁned as 1 [tRS (tCNS/tRNS)]/tCS), including
recombinant cultures (‘R’) and control cultures (‘C’) into
both selective (‘S’) and nonselective (‘NS’) media. Growth
curves were analyzed for the minimum time, t, where
OD600 0.4. Thus, tRS/tCS describes the growth advantage
of recombinants in selective media (tRS), compared with
negative controls in selective media (tCS). To normalize for
disparate inoculums (due to variable culture growth or
pipetting error), we divide by the corresponding ratio for
nonselective media (tRNS/tCNS). When tCS >> tRS, there
is no growth of negative controls in the selection,
limtCS!1 tRStCS ¼ 0, and NSA ! 1. If the selection has
failed and there is no selective advantage, then tRS tCS,
tRS/tCS! 1, and NSA ! 0.
High-throughput sequencing of tolC counter-selection
escape clones
To generate tolC counter-selection escape clones (SDS-
resistant, colE1-resistant), we ﬁrst cultured EcNR2.tolC+
in LBL plus SDS. Conﬂuent cultures were then passaged
1:100 into LBL plus colE1 (counter-selection #1), then
stamped into SDS (selection #2), then into colE1
(counter-selection #2), etc., until the fourth selection,
after which each well was streaked onto SDS to isolate
clones that were picked into LBL plus SDS & colE1 for
expansion and library preparation. Whole genome library
preparation was carried out based on previously published
protocols (32). Complete methods can be found in the
Supplementary Methods. Sequencing was carried out on
an Illumina HiSeq using 50 base pair paired-end reads,
which yielded 6.46 107 total reads. Raw reads were
aligned to the E. coli K12 MG1655 reference genome
(U00096) using BWA, and single nucleotide variants
(SNVs) were called using the software tools GATK (33),
SAMTools (34) and Freebayes (35) according to previ-
ously published methods (1). De-multiplexing the reads
by barcode averaged 6.6 105±2.7 105 reads/barcode
(min, max: 1.95 105, 1.56 106), which translates into
best-case read depth of 14.2±5.8 (min, max: 4.2, 33.7).
We identiﬁed 21 SNVs that deviated from reference in
most of the 96 genomes (17 in 96 of 96, 2 in 95 of 96, 1
in 93 of 96 and 1 in 53 of 96 genomes), suggesting EcNR2-
speciﬁc variants unrelated to the escape phenotype. These
SNVs are reported in Supplementary Table S1.
RESULTS AND DISCUSSION
Motivations for CoS-MAGE cycling
Since 2009, MAGE has been the subject of constant
technological development. We analyzed AR frequencies
across 30 genomic loci on both replichores (1) to assess
how AR frequencies have improved with recent strain
modiﬁcations (Figure 1A). We chose to average AR
frequencies for three 10-plex oligo pools to control for
locus- and oligo-speciﬁc variance. The far left bar of
Figure 1A shows the population distribution of edits in
EcNR2 after a single cycle of MAGE. Importantly, 72%
of the population is unmodiﬁed and only 8.3%of the popu-
lation harbors more than a single edit, yielding a popula-
tion average of 0.43±0.06 edits/clone/cycle (Figure 1B),
demonstrating that repeated cycling is crucial to attain
complex genotypes with MAGE. Co-selection in EcNR2
halves the unmodiﬁed portion of the population (35%) and
signiﬁcantly increases the population average to
1.39±0.05 edits/clone/cycle (***P< 0.0001, MAGE
versus CoS-MAGE), conﬁrming the signiﬁcant linkage
between selectable and nonselectable mutations (24). A
single cycle of MAGE in EcNR2.nuc5-.dnaG_Q576A
(22,23) resulted in 2.87±0.11 mean edits/clone/cycle and
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Figure 1. Repetitive tolC counter-selection rapidly generates a dysfunctional phenotype. (A and B). To motivate our work and demonstrate CoS-
MAGE in improved strains, we averaged allele conversion data from recent studies (22,23) across 30 genomic loci [Sets 1–3 from (22,23)]. The data
are reported as (A) Mean Allele Conversion±SD of each population (n=212, 821, 538, 561, 330, respectively) with the population mean reported
within its respective bar, and (B) as a stacked bar graph where each color indicates the frequency of clones bearing that number of allele conversions.
(C). The data from strain EcNR2.Nuc5-.dnaG_Q576A were used to model the allele conversion distribution through 10 cycles of CoS-MAGE. This
model did not account for any positional dependence for conversion of certain pairs of alleles (See Supplement and Figure S2). (D). A workﬂow
diagram showing how the dual selectable marker, tolC, can be used for CoS-MAGE. Starting in the bottom left corner, the tolC+ genotype is
recombined with a multiplexed oligo pool (gray oligos) plus the tolC_mut inactivation oligo (red). tolC recombinants pass subsequent counter-
selection in colE1, whereas the parental genotype is killed off (bottom right corner). Counter-selected tolC population (top right corner) is then
recombined with a multiplexed oligo pool (gray oligos) plus the tolC_rev reactivation oligo (green). tolC+ recombinants pass subsequent tolC
selection (bottom left corner), whereas the parental tolC genotype is killed (top left corner), and thus completes a tolC selection/counter-selection
cycle (2 CoS-MAGE cycles). (E). Selection performance of CoS-MAGE cycling on EcNR2.2223749::tolC using three different concentrations of the
selectable oligo (0.2, 0.5 and 2 mM) and the same concentration of the multiplexed, nonselectable oligos (5mM), quantiﬁed as Normalize Selective
Advantage (NSA, described in ‘Materials and Methods’ section) and presented as mean±St. Dev. (n=5+). Statistical signiﬁcance was tested using
a Kruskal–Wallis One-way ANOVA followed by Dunn’s test, where *P< 0.05, **P< 0.01 and ***P< 0.001. The plot background color indicates the
selection (green) or counter-selection (red) step associated with that CoS-MAGE cycle. Over successive CoS-MAGE cycles, all three lineages escaped
and NSA ! 0.
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only 9.6% of the population was unmodiﬁed (Figure 1A,
right bar). Although MAGE performance in this strain is
attractive, CoS-MAGE using selectable markers is not
amenable to cycling and requires time-intensive screening
between each CoS-MAGE cycle.
While MAGE has achieved highly modiﬁed genotypes
through extensive cycling (1) and CoS-MAGE can achieve
highly modiﬁed genotypes after a single cycle (23), thus we
were interested to model continuous CoS-MAGE cycles
using the AR frequency data gathered for one CoS-
MAGE cycle using EcNR2.dnaG_Q576A (23). Our
models (Figure 1C and Supplementary Figure S2)
predict that >50% of the population would achieve a
completely modiﬁed state (10 of 10 edits) after 10 cycles
of CoS-MAGE, whereas MAGE in EcNR2 could only
accomplish this after 90 cycles [Supplementary Figure S3
of (17)], suggesting that CoS-MAGE in optimized strains
is roughly 10-fold more efﬁcient than MAGE at achieving
allelic diversity (please see Supplement for additional dis-
cussion of our models).
Repetitive tolC counter-selection rapidly generates a
dysfunctional phenotype
We reasoned that a dual selectable marker would enable
a variety of convenient genome editing applications,
including CoS-MAGE, but would require serially using
both selection schemes in a continuous workﬂow. We
envisioned that CoS-MAGE using the dual-selectable
marker, tolC, would follow the workﬂow diagram in
Figure 1D, which depicts a continuous cycle of
inactivating tolC–performing the counter-selection
(colE1)–restoring tolC–performing the selection (SDS)–
etc. To test tolC as a dual selectable marker in CoS-
MAGE cycling, we generated an EcNR2-based strain
(naı¨ve to the tolC counter-selection at the outset) as a
test case. We began by deleting the endogenous tolC at
nt 317 6137, then inserting a new tolC at nt 2 223 749 and
using it to co-select for 10 TAG ! TAA mutations
[between 2 113 931 and 2 223 066 nt from (1)] in cycles
of CoS-MAGE (Figure 1D). We quantiﬁed selection
performance in these experiments by computing a
Normalized Selective Advantage value (NSA, see
‘Materials and Methods’ section for discussion of the
metric and its features/drawbacks). NSA=1 signiﬁes
perfect selection with no negative control escape
(Supplementary Figure S3A, left panel), and NSA=0
indicates complete selection escape (Supplementary
Figure S3A, right panel).
We conducted ﬁve replicates of counter-selection-
coupled, endogenous tolC deletion using 5 105 cells
and observed substantial escape (NSA=0.44±0.13,
Cycle 1, Figure 1E) after a single counter-selection.
We inserted the new tolC at nt 2 223 749 and continued
with CoS-MAGE cycles using different concentrations of
selectable oligos (0.2, 0.5 and 2 mM), which exhibited stat-
istically signiﬁcantly different NSAs (**P< 0.01, 2 mM
versus both 0.5 and 0.2 mM). Higher concentrations of
selectable oligo correlated with higher NSA, consistent
with an increased mole fraction of an oligo increasing its
allele recombination (AR) frequency within a multiplexed
pool (24). Over subsequent cycles, NSA continued to
decrease and the 0.2 and 0.5 mM lineages completely
escaped at Cycle 5 (0.01±0.02 and 0.03±0.06, respect-
ively; P=n.s., 0.2 versus 0.5 mM), whereas the 2 mM
lineage completely escaped at Cycle 6 (0.06±0.06;
*P< 0.05, 2 mM versus 0.5 and 0.2 mM). These data
suggest that tolC could not be used for repetitive selec-
tion/counter-selection schemes.
Supplemental experiments (Supplementary Figure S3)
supported the hypothesis that counter-selection escape
was mutational and not due to colE1 degradation
or loss of activity (Supplementary Figure S3B). Sanger
sequencing conﬁrmed that the tolC coding region was
intact. Thus, we hypothesized that whole-genome re-
sequencing could shed light on counter-selection escape
strategies.
High-throughput sequencing diagnosis of tolC
counter-selection escape
To identify alleles that cause the tolC counter-selection
escape, we re-sequenced the genomes of 96 independent
tolC counter-selection escape clones (see ‘Materials and
Methods’ section). Our analysis relies on re-sequencing
many independent counter-selection escape clones to cat-
egorize genomic variants into those that are causal and
those that are unrelated to counter-selection escape.
Across the 96 genomes, there was an enrichment (108 of
3272 total mutations in the data set) for mutations in a
4-kb window from 774 000 to 778 000 nt, corresponding to
the tolQRA operon (Figure 2A and Supplementary
Figure S3D). tolQ contained 14, tolR contained 8, and
tolA contained 23 distinct mutations in their respective
coding regions (Figure 2B, bottom panel), yet zero muta-
tions were identiﬁed in ybgC, also encoded by the tolQRA
operon. After tolQ/tolR/tolA, lhr, ydeK and uvrB con-
tained the next most distinct mutations each (n=5), con-
sistent with their large coding sizes (4687, 3978 and
2022 bp, respectively). The tolQ, tolR and tolA mutations
were enriched for start codon mutations, premature stop
codons and frameshifts (87% of all distinct mutations
in tolA, 71% for tolQ and 63% for tolR, Figure 3C).
Aside from the tolQRA operon, no other 4 kb window
contained >13 total mutations, but there were a number
of distinct mutations that were observed in multiple in-
dependent genomes (Figure 2B, columns to right of
break in x-axis), necessitating validation. Finally and
perhaps most indicative of causality, 89 of 96 genomes
in the dysfunctional clone set contained at least one
mutation in tolQRA.
Of the seven remaining dysfunctional genomes that
lacked tolQRA mutations, two genomes shared the same
nonsynonymous tolC L235P mutation, which is located
on the exterior face of the PP-spanning equatorial
domain of tolC, which protrudes from the exterior of
the channel. Based on docking models (36), this protru-
sion is involved in stabilizing protein–protein interactions
between TolC and its active transport systems in the IM
(e.g. acrAB). We posit that the kink in the polypeptide
backbone contributed by proline may interfere with inter-
actions between TolC and TolA, perhaps making TolA
Nucleic Acids Research, 2014, Vol. 42, No. 7 4783
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less available for colE1 binding (37). The ﬁve remaining
genomes did not share any common mutations, suggesting
rare escape mechanisms.
Assessing causality of alleles identiﬁed via high-throughput
sequencing
To functionally assess the alleles identiﬁed by sequencing,
we designed MAGE oligos to generate the 55 most
abundant mutations (XM oligos), and to knockout the
20 most frequently mutated coding regions (cvrALL
oligos) seen in our data set. Each of these oligos was
recombined into EcNR2.tolC+ and counter-selected
using colE1. We hypothesized that oligos that confer
mutations causing tolC counter-selection escape will
shorten the culture time in colE1 that is required to
reach OD600=0.4, as a larger portion of the preselection
population would be resistant to colE1. Presented in
Supplementary Table S2, we quantiﬁed relative
causality by including multiple controls, both
background (mock recombination) and positive (tolC
knockout recombination), which were used to calculate
Figure 3. tolQRA duplication enables stable CoS-MAGE cycling. (A). To probe the post-recombination growth phenotype of Nuc5-based strains,
we individually reverted each of the four inactivated nucleases: exoX+ (cyan); recJ+ (orange); xonA+ (red); xseA+ (purple). As controls, we included
EcNR2 (Nuc5+, blue) and EcNR2.Nuc5 (black). To study the poor post-recombination recovery phenotype associated with EcNR2.Nuc5, we
recombined these six strains with a 5.2 mM multiplexed oligo pool, then monitored growth post-recombination. (B). To understand whether nuclease
reversion results in inferior CoS-MAGE performance to Nuc5, we tested Nuc5, the recJ reversion (recJ+) and the xonA reversion (xonA+)
strains in a single cycle of CoS-MAGE. The mascPCR data are presented as Mean Allele Conversion±SD. Statistical analysis (Kruskal–Wallis
ANOVA) revealed that the means were not statistically signiﬁcantly different (P> 0.05). Moving forward, we implemented the recJ reversion in
EcM2.0 (EcNR2.dnaG_Q576A.xseA-.exoX-.xonA-.1255700::tolQRA). (C and D). EcM2.0 was subjected to continuous CoS-MAGE cycling of
Oligo Set 1 (22,23) using the endogenous tolCWT. We inoculated selections (SDS) using 5 106 cells/well, and counter-selections using 5 104
cells/well (C) or 5 105 cells/well (D). After each respective selection, clones were plated and screened for allele conversions at the 10 loci of interest
using mascPCR.
Nucleic Acids Research, 2014, Vol. 42, No. 7 4785
Normalized Culture Time (see Supplemental Methods for
Deﬁnition of this metric). An oligo exhibiting a
Normalized Culture Time of 0 encodes an escape
mutation, whereas an oligo exhibiting a Normalized
Culture Time of 1 encodes an unrelated mutation. We
acknowledge that the oligo-dependent variance in AR fre-
quency seen in MAGE (1,17) will introduce an additional
variable to our readout, leading to increased Type II
errors.
Normalized Culture Time for all putative dysfunc-
tional oligos fell between 0.13±0.01 and 1.31±0.12
(Supplementary Table S2). As expected, the cvrALL_
tolC_3 oligo generates colE1 resistance through tolC
knockout with a Normalized Culture Time of
0.01±0.01. Causal mutations (deﬁned as Normalized
Culture Time< 0.6) included four frameshifts in tolA, 1
SNV in tolA, 2 frameshifts in tolR, 2 SNVs in tolR, as
well as the cvrALL oligos for tolQ and tolR. The
cvrALL oligo for tolA led to a Normalized Culture
Time of only 0.73±0.11, possibly because recombination
frequency is low for this oligo or because in-frame ATG
codons (such as M54, M67 or M83) rescue tolA transla-
tion downstream of the premature stop introduced by the
oligo. Borderline mutations (deﬁned as 0.6Normalized
Culture Time< 1.0) included two frameshifts in tolA, one
frameshift in tolQ and the cvrALL oligo for tolA.
Examples where we invalidated borderline mutations like
ogt, recR and treB can be found in the Supplement. The
remainder of the 75 tested MAGE oligos produced
Normalized Culture Times 1, suggesting that they are
not involved in counter-selection escape.
The domain structure of the 421 amino acid TolA
protein corresponds to a single pass transmembrane
protein with a tight, a-helical domain (38) extending into
the PP. Published work has shown that a 1 frameshift in
tolA after I400 led to colE1 resistance (37), which agrees
well with our data set showing a prevalence of tolA
frameshifts that led to colE1 resistance (including
XM_tolA_776642_GGCAA_G where translation falls
out of frame after G359; Supplementary Table S2), and
suggests that colE1 engages the C-terminus of tolA. This
mechanistic insight is further supported by the fact that 67
out of a total of 108 tolQRA mutations (62.0%) were in
tolA (Figure 2B, top panel), which is a slight enrichment
over the frequency expected based on coding region size
alone (53.0%). Beyond the colE1-TolA interaction, proper
activity of the entire TolQRA complex is required, as sug-
gested previously (39) and as evinced by the causal
cvrALL mutations for tolQ and tolR (Supplementary
Table S2). TolQ has been implicated as a molecular
motor for the Tol complex (39,40), while TolR is
required to stabilize TolQ in the IM (39). In fact,
TolRD23 mutations, which were previously shown to
abolish the TolQ-TolR interaction and increase TolQ
turnover [TolRD23A and TolRD23R (39)], were also seen
in this data set (TolRD23G) and were determined to be
causal when introduced by XM_tolR_775139_A_G
(Supplementary Table S2). Taken together, these results
validate the hypothesis that loss-of-function mutations in
tolQRA lead to tolC counter-selection escape.
Engineering a strain with improved tolC counter-selection
Based on a mechanistic understanding of tolC counter-
selection escape born from whole-genome re-sequencing,
we hypothesized that duplicating the tolQRA operon
would safeguard against loss-of-function mutations
and make the tolC counter-selection more robust
(Figure 3C). To guide insertion of the duplicated
tolQRA operon, candidate destinations were chosen to
be separated from the wild-type operon by at least one
essential gene, reducing the chances of recA-mediated re-
combination between identical operons. We generated the
tolQRA-duplicated strain, EcNR2.1255700::tolQRA.tolC+
and inoculated 32 replicates of 106 mid-log EcNR2.tolC+
or EcNR2.1255700::tolQRA.tolC+ (tolQRA duplicated)
cell into LBL plus colE1 to analyze growth. All
EcNR2.tolC+ replicates escaped, attaining OD600=0.4
at 781.1± 18.2 min (mean±stdev), whereas only 1 of
the 32 EcNR2.1255700::tolQRA replicates grew over the
48 h course (OD600=0.4 at 919.5min). This demonstrates
that tolQRA duplication protects against tolC counter-
selection escape. Importantly, tolQRA duplication led to
no apparent phenotypes in growth or recombination.
tolQRA duplication enables stable CoS-MAGE cycling
Leveraging reduced tolC counter-selection escape, we
attempted to perform continuous stable CoS-MAGE
cycling on a tolQRA-duplicated version of a recently
optimized strain (22,23). However, because Nuc5-based
strains exhibit a slow recovery phenotype after recombin-
ation (22), this modiﬁcation is not suited for cycling. By
individually reverting each inactivated nuclease in Nuc5,
we determined that recJ reversion reduced this recovery
phenotype (Figure 3A) without compromising the
improved MAGE performance seen in the Nuc5- back-
ground (Figure 3B, see Supplement for our complete
line of reasoning and discussion of these data). We
deﬁned EcNR2.tolC.dnaG_Q576A.exoX-.xonA-.xseA-
as EcM1.0 (for E. coliMAGE-optimized), then duplicated
tolQRA in EcM1.0 to produce EcM2.0.
To test CoS-MAGE cycling in EcM2.0, we cycled the
endogenous tolC to co-select for 10 nearby oligo-encoded
TAG to TAA mutations [Set #1 from (22)]. We performed
tolC selections (SDS) using 5 106 cells/selection, and per-
formed tolC counter-selection (colE1) using 5 104
(Figure 3C), 5 105 (Figure 3D), 5 106 cells/counter-
selection to test if all three counter-selection inocula
would support continuous and stable cycles of selection/
counter-selection. The ﬁrst two lineages maintained ideal
selections for 10+ cycles, whereas the 5 106 cells/
counter-selection lineage escaped during the third
counter-selection. MascPCR data from the two lineages
exhibiting ideal selections (Figure 3CD) showed that
both rapidly moved through the recoding landscape
from unmodiﬁed (at Cycle 0) to completely modiﬁed (at
Cycle 10), with 92% of the 5 104 lineage and 70% of the
5 105 lineage exhibiting 10 of 10 conversions. There was
more diversity in the 5 105 lineage, consistent with larger
counter-selection library size, while the 5 104 lineage
often collapsed diversity to a single genotype (compare
odd cycle #’s of Figure 3C and D, please see the
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Supplement for additional discussion of these results in
the context of our model). Taken together, these data sug-
gest that the tolC counter-selection in tolQRA-duplicated
lineages such as EcM2.0 supports stable CoS-MAGE
cycling, but that a careful balance between library com-
plexity and escape frequency must be maintained.
Other approaches to reduce tolC counter-selection escape
Since tolC has been implicated in efﬂux of a variety of
compounds (electrolytes, ions, antibiotics, detergents,
etc.), we searched for other tolC counter-selection agents
that use a different mechanism than colE1. Assuming
mechanistic independence, the escape frequency of the
simultaneous application of two orthogonal counter-
selection agents would be the product of the escape
frequencies of each individual agent, thereby increasing
the stringency of counter-selection. Vancomycin is an
amino-glycoside antibiotic that inhibits the D-Ala-D-Ala
Ligase and requires tolC to gain access to the PP in gram-
negative bacteria (41). We tested the tolC-dependence of
vancomycin across a dilution series from 0.5 to 512 mg/ml,
using 106 EcNR2 cells (Figure 4A, top panel) or 106
EcNR2.tolC cells (Figure 4A, bottom panel).
EcNR2.tolC exhibited an optimal selective advantage
7 doublings (377 minutes) in 64 mgvancomycin/ml. We
demonstrated the mechanistic independence of vanco-
mycin escape from colE1 escape by showing that
vancomycin selection was still effective on the 96 tolC
counter-selection escape clones used for whole-genome
re-sequencing (Figure 4B). Thirty-ﬁve clones exhibited
no growth over 24 h, and the 61 clones that grew
averaged a delay of 433±118min (minimum 176min)
with respect to nonselective media controls, similar to
that of a colE1-naı¨ve EcNR2 control (Figure 4B, blue
square). These results suggest that applying colE1 and
vancomycin together could further reduce tolC counter-
selection escape.
Other approaches to improve the tolC counter-selection
included increasing TolC turnover and restoring mutS
mismatch repair. We attempted to ssrA tag tolC to
reduce recovery time before tolC counter-selection, but
found it difﬁcult to balance adequate expression levels
with quick turnover (Supplementary Figure S5, see
Supplement for further discussion of these experiments).
Mismatch repair deﬁciency improves  Red-mediated AR
frequencies (21), but also increases mutagenesis by 10- to
100-fold (42), thereby increasing the frequency at which
tolC counter-selection escape mutations arise. For facile
restoration of mismatch repair as needed, we restored
mutS in place of mutS::cat by selecting for insertion of
tolC coupled to the 1.2 kb N-terminus of mutS, then
counter-selecting for replacement of tolC using the
1.5 kb C-terminus of mutS, and ﬁnally using MAGE to
inactivate the restored coding region to re-enable MAGE.
This strain is designated EcM2.1.
After implementing all strain improvements, we
quantiﬁed tolC counter-selection escape frequencies with
agar plates containing colE1 (Figure 4C), prepared as
described in the ‘Materials and Methods’ section, and
validated as described in the (Supplementary Figure S6).
EcNR2 escaped counter-selection at a frequency of 3.4E-
5±5E-6 on colE1 agar plates (LBLCCo), while tolQRA
duplicated lineages (EcM2.0) exhibited a 40-fold reduc-
tion in escape frequency (8.5E-7±1.4E-7). Notably,
triplicated tolQRA or duplicated btuB strains did not
exhibit reduced escape frequencies compared with
EcM2.0, suggesting higher copy number does not offer
additional protection from tolC counter-selection escape.
While the escape frequencies for agar plates containing
only vancomycin (LBLCV) were very high, for example
8.3E-2±3.6E-2 in EcNR2, escape frequencies for plates
containing colicin and vancomycin (LBLCCoV) were very
low, for example 2.0E-9±6E-10 in EcM2.0, which was a
400-fold reduction in escape frequency from that on
LBLCCo and a 170 000-fold reduction from LBLCV
alone. Platings on LBLCV also suggested that tolQRA
duplication (EcM2.0-based strains) is associated with a
150-fold reduction in vancomycin escape, despite seem-
ingly independent mechanisms (Figure 4B). Finally, mutS
reactivation in EcM2.1 led to the lowest observed escape
frequency (4.3E-11, or 1 clone in 2.3E10 total cells plated,
Figure 4C), making tolC counter-selection as effective as
many selectable markers. Low escape frequencies will
support larger library sizes in the tolC counter-selection
and enable the use of tolC for inefﬁcient genomic manipu-
lations, such as conjugal transfer of large genome
segments (1).
CONCLUSIONS
Robust selectable markers are essential for basic molecu-
lar biology research as well as genome engineering appli-
cations (1,25,29). To support these efforts, we have
developed an extensible workﬂow to diagnose mechanisms
of selection escape and have developed several strategies
to improve selection robustness. Based on our experience
with dual selectable markers such as galK (10), thyA (11),
hsvTK (12) and tetA (13), we chose tolC (14) as a test case
because of convenient selection (SDS) and counter-
selection (colE1) schemes. We used whole-genome
re-sequencing for the unbiased identiﬁcation of genes
involved in tolC counter-selection escape. The results
were consistent with biochemical studies (37–39)
indicating that tolQ, tolR and tolA are involved in colE1
import, but surprisingly indicated no likely role for btuB
(40). Based on these results, we found that tolQRA dupli-
cation, but not btuB duplication, reduced tolC counter-
selection escape frequency by 40-fold. We further
reduced tolC counter-selection escape 425-fold by
using vancomycin together with colE1. In EcM2.1
(mutS+), this resulted to a 1E-11 counter-selection
escape frequency, which totals a 1.3E6-fold improvement
over our initial methods. Similar to how vancomycin and
colE1 synergize to improve the tolC counter-selection, our
colleagues (43) recently published on a dual-selectable,
tetA-sacB tandem cassette where fusaric acid and
sucrose synergize to achieve more robust counter-selection
than either marker alone. Robust dual-selectable markers,
like tolC and tetA-sacB, are welcome and complementary
tools for genome editing. It will be interesting to compare
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Figure 4. Other approaches to reduce tolC counter-selection escape. (A) We tested the tolC-dependence of vancomycin sensitivity on EcNR2.tolC+
(top panel, blue) and EcNR2.tolC (bottom panel, red) by kinetically measuring growth across a 2-fold dilution series from 2 mgvanc/ml (lightest
curve) to 512mgvanc/ml (darkest curve). At 64 mgvanc/ml (curves marked with ‘x’), EcNR2.tolC
 cells grew normally, whereas EcNR2.tolC+ growth was
impaired, leading to a maximal growth advantage. (B) To test mechanistic independence of counter-selection in vancomycin from that of colE1, we
cultured the escape clones used for whole genome re-sequencing (n=96, 106 cells/well, black circles) with or without 64 mgvanc/ml. The data are
presented as the Growth Delay (in minutes) in vancomycin with respect to no vancomycin. Many clones (n=35) did not show any growth within the
48-h kinetic experiment and were plotted as ‘No Growth’ above the broken y-axis. Of the clones that did grow (n=61), the mean (heavy dashed line)
and standard deviation (light dashed line) of Growth Delay are plotted with the data. An EcNR2.tolC+control was also tested (blue square), to show
how vancomycin delays naı¨ve tolC+ cells. (C). To quantify our improvements to the tolC counter-selection, we measured escape frequency by plating
known amounts of tolC+ strains onto vancomycin plates (LBLCV), colicin E1 plates (LBLCCo) and colicin E1/vancomycin plates (LBLCCoV). Data
were gathered by counting colonies from at least four independent biological replicates and are presented as Mean±SEM, except for EcM2.1 on
LBLCCoV, which is based on a single data point (1 escape clone out of 2.32 1010 total cells plated).
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these systems (and others as they emerge), as fundamental
aspects of each system will dictate relative performance.
To conclude, we have created an optimized strain for gen-
ome engineering, called EcM2.1 (E. coliMAGE-optimized
2.1), on which we performed stable, continuous cycles of
CoS-MAGE using tolC to generate a completely modiﬁed
population of cells possessing 10 of 10 desired modiﬁca-
tions without requiring any intermittent screening or
direct selection. This unprecedented capability will facili-
tate repetitive selection/counter-selection cycles using
large library sizes, which will be an important tool for
genome editing and synthetic biology.
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